cevac md hvt suspension and solvent for suspension for injection for chickens 2000 - 8000 pfu
Сева Анимал Хелт България ЕООД - Вирусът на херпес Турция (ХВТ, Марек,вирусни заболявания и), 3 серотипа, щама на файлова система-126 - суспензия и разтворител за инжекционна суспензия - 2000 - 8000 pfu - пилета
intracox oral 25 mg/ml
interchemie werken de adelaar b.v - Толтразурил - перорален разтвор - 25 mg/ml - кокошки, пуйки
limoxin - 200 la 200 mg/ml
interchemie werken de adelaar b.v. - Окситетрациклин (като дигидрат) - инжекционен разтвор - 200 mg/ml - говеда, кози, овце, свине
limoxin 100 100 mg/ml
interchemie werken de adelaar b.v. - Окситетрациклин (под формата на хидрохлорид) - инжекционен разтвор - 100 mg/ml - говеда, кози, овце, свине
tetravet l.a. 200 mg
ceva sante animale - Окситетрациклин - инжекционен разтвор - 200 mg - говеда, овце, свине
cevac md rispens concentrate and solvent for suspension for injection for chickens 800-5000 pfu
Сева Анимал Хелт България ЕООД - live marek’s disease virus (mdv) serotype 1, strain cvi-988 - инжекционна суспензия - 800-5000 pfu - пилета
leqvio
novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - Липидни модифициращи агенти - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.
intractan-bg 25 mg 25.0 mg/ml
interchemie werken “de adelaar” b.v. - cefquinome (като сулфат) - инжекционна суспензия - 25.0 mg/ml - говеда, прасета
ontilyv
bial portela & companhia s.a. - opicapone - Паркинсонова болест - Антипаркинсонови лекарства - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
zokinvy
eigerbio europe limited - lonafarnib - progeria; laminopathies - Други стомашно-чревния тракт и обмяната на веществата средства, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.